Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy
oleh: Ayad M. Al‐Katib, Hussein Gaith, Dahlia Sano, Sayf Al‐Katib, Michelle Bonnett, Zyad Kafri
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2020-09-01 |
Deskripsi
Abstract Ibrutinib is approved for chronic lymphocytic leukemia (CLL). However, its role in the treatment of multiple myeloma (MM) is not clear and is under investigation. We report a case of CLL that developed MM while on therapy with ibrutinib indicating that this drug may not be active against MM.